Ladenburg Thalmann Financial Services’s Lipocine LPCN Stock Holding History
Bought
Maintained
Sold
Other funds holding LPCN
SM
CH
CL
Ladenburg Thalmann Financial Services's LPCN Position: Q4 2019 in Review
Ladenburg Thalmann Financial Services increased its Lipocine (LPCN) stake by 30% in Q4 2019, buying an estimated $3.02K and bringing the position to 509 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4964.
Ladenburg Thalmann Financial Services first reported a position in LPCN in Q2 2014 and has held it in 23 quarters since. The position peaked at $54K in Q4 2015. 32 funds tracked by Wall St. Rank hold LPCN as of Q4 2019.
- Ladenburg Thalmann Financial Services held 509 shares of Lipocine worth $3K as of Q4 2019.
- Ladenburg Thalmann Financial Services bought 118 Lipocine shares in Q4 2019, an estimated $3.02K.
- Lipocine made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4964 holding.
- Ladenburg Thalmann Financial Services first reported a position in Lipocine in Q2 2014 and has held it in 23 quarters since.
- Ladenburg Thalmann Financial Services's Lipocine position peaked at $54K in Q4 2015.
- 32 funds tracked by Wall St. Rank held Lipocine as of Q4 2019.
Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.